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Abstract 
Purpose: To investigate the antidiabetic potential of Emblica officinalis, Gaertn on diabetic rats. 
Methods: The study investigated the anti-hyperglycemic potential of the aqueous fruit extract of amla 
(E. officianalis, for eleven weeks in streptozotocin-induced diabetic obese rats. The study utilized forty 
eight rats divided into four groups as follows. Untreated diabetic control (group 1) received 2 % gum 
acacia as vehicle; groups 2 and 3 were diabetic rats administered the fruit extract in 400 and 200 mg/kg 
doses, respectively; while group 4 (diabetic rats) received metformin (600 mg/kg) as reference drug. 
The parameters assessed weekly were body weight, as well as fasting blood glucose, cholesterol and 
triglyceride levels in venous blood.  
Results:  Both plant extract-treated groups showed significant (p ≤ 0.001) reduction in blood glucose 
levels in the fifth and sixth weeks compared to the metformin-treated group. Body weight significantly 
increased during the fourth, fifth and sixth weeks, being more pronounced in the extract-treated groups 
(272 ± 15.0 g and 227 ± 7.23 g for 200 and 400 mg/kg doses, respectively; the corresponding body 
weight for untreated diabetic control was 197 ± 9.83 g. Furthermore, both extract doses (200 and 400 
mg/kg) produced significant decrease (p ≥ 0.05) in serum glucose (186 ± 15.5 mg/L and 146 ± 15.1 
mg/L), cholesterol (143.6 ± 0.86 mg/L and 151.0 ± 0.77mg/L) and triglyceride (82.6 ± 0.51mg/dl and 
84.8 ± 0.84 m/dl) levels, respectively, similar to the metformin treated group. 
Conclusion: The anti-diabetic activity of the aqueous extract of E. officianalis used showed a better 
potential than metformin.  
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Diabetes mellitus is a disease characterized by 
an altered glucose homeostasis and persistent 
hyperglycemia leading to many complications. 
Around 230 million people worldwide have been 
affected by diabetes and around 366 million 
people are expected to get affected by 2030 [1]. 
The pattern of prevalence has been the same in 
the Gulf including Saudi Arabia. Saudi Arabia 
has experienced an exponential socioeconomic 
growth over the past few decades which have led 
to a sedentary and affluent lifestyle of the people 
in the urban society. A recent follow up 
epidemiological study shows an alarming 
increase in the prevalence of diabetes during the 
past few years [2]. This has stimulated public 
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awareness of this endocrine disorder and the 
identification of risk factors associated with it.  
 
Emblica officinalis, Gaertn commonly known as 
Indian gooseberry or amla in India, is a member 
of the small genus of Emblica (Euphorbiaceae). It 
is an important dietary source of vitamin C, 
minerals and amino acids, and also contains 
phenolic compounds [3]. The aqueous fruit 
extract of amla has been reported to exhibit 
hypolipidaemic [3], antidiabetic and anti-
inflammatory activities. In the past decade, the 
aqueous fruit extract of amla has been tested for 
various pharmacological activities. Some of 
these activities includeantioxidant properties 
[4,5], and it has also been reported that the 
aqueous fruit extract of amla is a potent inhibitor 
of lipid peroxide formation and a scavenger of 
hydroxyl and superoxide radicals in vitro [6]. The 
present study includes a comparative 
assessment of the antihyperglycemic potential of 
the aqueous fruit extract of amla and a 
commonly used antidiabetic drug. Blood glucose, 
body weights and other related markers such as 
serum cholesterol and triglycerides associated 
with the progression of diabetes were studied in 






All chemicals and drugs were obtained 
commercially and of analytical grade. They 
include streptozotocin (Sigma Aldrich, USA) and 
metformin (Merck Serono, Middle East). 
Commercially available kits using Reflotron 
Assays (Roche) were used for the determination 
of serum glucose, cholesterol and trigycerides 
(United Diagnostic Company, Saudi Arabia).  
 
Plant material and preparation of extract 
 
Shade-dried amla fruits were obtained from the 
local market in Riyadh city, Saudi Arabia. The 
fruits also authenticated and found in the 
Botanical garden at King Saud University, were 
identified and authenticated by Dr Iram Siddique 
in the Department of Botany at King Saud 
University, Riyadh. A voucher specimen (voucher 
no. 2981) of the fruit was deposited in the 
herbarium of the Faculty of Science, King Saud 
University, Riyadh, Saudi Arabia. 
 
For the preparation of the aqueous fruit extract, 
100 g of the dried amla fruits were ground in an 
electrical grinder and  soaked in 500 ml distilled 
water [7]. The mixture was left for 24 h with a 
magnetic stirrer at room temperature. Twenty 
four hours later, the mixture was strained out 
using a fine sieve and the crude extract air-
evaporated for 3 days [8]. The aqueous fruit 
extract was then orally administered to the rats in 
the two extract treatment groups at doses of 200 
and 400 mg/kg body weight, respectively. 
 
Experimental animals and induction of 
diabetes 
 
Male Wistar rats weighing 200 - 250 g were 
used. The animals were fed with standard 
laboratory chow obtained from the animal house 
at King Saud University and had free access to 
water under well ventilated conditions of 12 h day 
and dark cycles each. The animals were 
acclimatized to laboratory conditions prior to the 
experiment. The protocols were approved by the 
institution’s National Committee for Medical and 
Bio-ethics. The animals were handled according 
to standard protocols for the use of laboratory 
animals [9].  
 
Food was withdrawn 12 h prior to the induction of 
diabetes. Thereafter, they were injected with 
streptozotocin (70 mg/kg, i.p.) [8]. Five days after 
injection, the rats with fasting blood glucose 
higher than 200 mg/L were considered diabetic 
and used for the experiment [8]. Food was 




The forty eight rats were divided into the 
following groups and they were daily orally 
treated with the respective drugs as indicated for 
eleven weeks. Group 1; Untreated diabetic 
control (DC): diabetic rats administered 2 % gum 
acacia as vehicle, 2 and 3. Emblica officinalis 
aqueous fruit extract (400 and 200 mg/kg body 
weight) treated diabetic rats respectively, and 
group 4. Metformin injections for treated diabetic 
rats (600 mg/kg body weight) [8]. 
 
Blood sampling and biochemical analysis 
 
Daily before and after administration of the 
aqueous plant extract of amla and metformin, 
rats were anaesthetized using carbon dioxide. 
Venous retro orbital blood samples were 
collected in the fasting state at specific intervals 
using a glass capillary and collected in 
polystyrene tubes without anticoagulant [10]. 
Serum was separated by centrifugation at 3000 
rpm for 10 min after which it was tested for 
glucose. At the end of the experimental period, 
the blood samples collected were also tested for 
serum cholesterol and triglycerides. Samples 
were stored at -20 °C until assayed. 
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One-way analysis variance (ANOVA) was 
performed using GraphPad Prism statistical 
software. Tukey t-test was used for multiple 
comparisons. The values were considered 




The basal serum fasting glucose levels of the 
rats from all the four experimental groups were 
comparable (94 - 100 mg/dL) and there was no 
significant difference between the groups. In the 
first week after the administration of STZ (70 
mg/kg), the blood glucose level was increased in 
the diabetic group almost two-fold (120 - 280 
mg/dL). Groups administered both doses of amla 
(200 and 400 mg/kg) showed no significant 
difference from the metformin group. The blood 
glucose level of rats from all the treated groups 
showed a significant (p ≤ 0.001) decrease in 
compared to diabetic control; however, there was 
no significant difference observed between the 
amla-treated groups (Figure 1). 
 
The mean basal body weight of all experimental 
groups ranged from 184 -199 g and no inter-
group variation was observed. Post-
administration of STZ (week 1) resulted in 
increase in body weight in all the experimental 
groups. The body weight of diabetic control 
group was not significantly different (p < 0.05) 
from those of the extract-treated groups. While 
the body weight of the rats from the group 
treated with the lower dose of the aqueous fruit 
extract of amla (200 mg/kg) (p < 0.001), it, 
however, significantly higher than that of the 
metformin-treated group, the higher dose (400 
mg) of the aqueous fruit extract of amla group 
showed no significant difference in body weight. 
However, the body weight of rats in extract-
treated groups were not significantly different 
from that of diabetic control. There was also no 
significant difference in body weight between the 
two extract-treated groups (Figure 2). 
 
At the end of the experimental period, the level of 
serum cholesterol in diabetic control rats was 
significantly (p < 0.05) higher than in all the 
treated groups. On treatment with the plant 
extract a significant (p < 0.001) decrease in 
serum cholesterol level was observed for both 
extract doses (200  and 400 mg/kg) compared to 
diabetic control and metformin groups (Figure 3). 
There was a significant (p < 0.05) difference 
between the extract-treated groups. 
 
At the end of the experimental period, the level of 
serum triglycerides in diabetic control rats was 
significantly (p < 0.001) than in all the treated 
diabetic groups. A significant (p < 0.001) 
decrease in triglyceride levels was observed for 
both the amla aqueous fruit extract treated 




Figure 1: Effect of Emblica officianalis fruit extract on serum blood glucose level (mg/dL) of diabetic rats 
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                        Figure 4: Effect of Emblica officianalis on serum triglyceride levels in diabetic rats 
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Phytotherapy has a promising future in the 
management of diabetes, considering its less 
toxicity and fewer side effects compared to the 
synthetic drugs used [11]. Also, they are 
important sources of antioxidant molecules and 
novelty. Phytocompounds have been proven to 
be safe and efficacious with fewer side effects in 
comparison to the synthetic antioxidants which 
could possibly be carcinogenic in nature [11].  
 
Diabetes and obesity are chronic metabolic 
diseases that are associated with risk of 
hypertension, renal failure, coronary heart 
diseases, stroke, all being fatal [12,13]. The 
present study showed that treatment of STZ 
induced type I diabetic rats by amla aqueous fruit 
extract improved the antidiabetic effects.. 
Further, an experimental study on male wistar 
rats fed a high-fructose (65 %) diet for 1 week, 
and treated with an ethyl acetate (EtOAc) extract 
of amla, a polyphenol-rich fraction, at 10 or 20 
mg/kg body weight per day, showed that the 
extract alleviated the dyslipidaemia caused due 
to the fructose – induced metabolic syndrome 
[14]. Similar findings were reported in another 
study [15] on diabetic rats treated with a plant 
extract, powdered rhizome of Curcuma longa 
(turmeric) and the dried fruits of Emblica 
officinalis. The treatment achieved significant 
lowering of plasma glucose and glycated 
haemoglobin in diabetic rats comparable to that 
of the glyburide, a sulfonylurea drug, treated 
group. Most phenolic and flavonoids compounds 
are described as having anti-oxidative action in 
living systems, as they act as scavengers of free 
radicals [16].  
 
Thus there is a growing trend of using plant 
products in therapy as they are rich in these 
antioxidants. However, the non pharmacological 
management of type 2 diabetes should include 
an appropriate diet management. A myriad of 
foods like cereals, vegetables and spices have 
been assessed for their anti-hyperglycemic effect 
[17] in experimental as well as clinical studies. 
The present study showed that treatment of STZ 
rats with the extract improved insulin sensitivity. 
However, the plant extract had other effects such 
as anti-obesity although another study had 
reported no anti obesity effects [14].  
 
The findings in the present study demonstrate an 
antihypercholesterolic and antihypertriacyl-
glycerolaemic effect of the extract of amla at both 
doses used (200 and 400 mg/kg). Hypoglycemic 
herbs are widely used as nonprescription 
treatment for diabetes. However, few herbal 
medicines have been well characterized and 
demonstrated an efficacy in systematic clinical 
trials as those of synthetic drugs. Though these 
herbs may lower blood glucose, the test results 
are subject to several factors. For example, a 
plant may contain a myriad of components but 
only a few of which may be therapeutically 
effective. Therefore, phytochemical screening 




The use of phytonutrients to combat diabetes 
mellitus does offer a novel therapeutic approach 
to restore normal body functions. Findings from 
the present study indicate that the aqueous fruit 
extract of amla has a potential as an antidiabetic 
natural product. However, further 
pharmacological toxicological studies are 
required to determine its other effects and to 
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